ARCHIVES

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Major Clinical Trials Changes, Regional Groups, New Effort In Surgical Oncology

October 10, 1980

Research Policy: NIH Trials Don’t Enroll Enough Women to Allow Analysis, GAO Says in Report

May 12, 2000

Bush Appoints Andrew von Eschenback, Of M. D. Anderson, As 12th NCI Director.

December 7, 2001

FDA Can’t Prohibit Distribution of Articles, Books On Off-Label Drug Use, Judge Rules

August 13, 1999

Funding opportunties listed.

December 3, 2004

NSABP “Saddened” But Some Patient Advocates Hail “Courageous” Decision.

June 22, 2007